(19)
(11) EP 1 155 033 A1

(12)

(43) Date of publication:
21.11.2001 Bulletin 2001/47

(21) Application number: 99969282.5

(22) Date of filing: 15.12.1999
(51) International Patent Classification (IPC)7C07K 5/08, C07K 5/02, C07C 227/42, C07D 213/78
(86) International application number:
PCT/US9929/969
(87) International publication number:
WO 0040/601 (13.07.2000 Gazette 2000/28)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 30.12.1998 US 114289 P

(71) Applicant: Aventis Pharmaceuticals Products Inc.
Bridgewater, NJ 08807-0800 (US)

(72) Inventors:
  • AUTHELIN, Jean, Rene
    F-91180 Saint Germain les Arpajon (FR)
  • THOUZERY, Alain
    F-91600 Savigny sur Orge (FR)
  • MANGIN, Fabrice
    F-75018 Paris (FR)
  • BAILLY, Pierre
    F-95470 Fosses (FR)

(74) Representative: Jones, Stephen Anthony 
AdamsonJonesBroadway Business Centre32a Stoney Street
Nottingham NG1 1LL
Nottingham NG1 1LL (GB)

   


(54) PROCESS FOR PREPARING A STABLE NON-HYGROSCOPIC CRYSTALLINE N-[N-[N-(PIPERDIN-4-YL)BUTANOYL)-N-ETHYLGLYCYL]-(L)-ASPARTYL]-SS-CYCLOHEXYLALANINE AMIDE